Composition for medical purposes for use in targeted pharmaceutical therapies for the treatment of infectious diseases and disorders; Composition for medical purposes for use in targeted pharmaceutical therapies for the treatment of pulmonary viral infection; delivery agents for medical purposes for use in targeted pharmaceutical therapies for the treatment of infectious diseases; delivery agents for medical purposes for use in targeted pharmaceutical therapies for the treatment of pulmonary viral infection; drug delivery agents for medical purposes consisting of compositions that facilitate the delivery of a wide range of pharmaceutical based therapies; vaccines; vaccine preparations; medical preparations for the treatment of infectious diseases; pharmaceutical preparations and substances for the treatment of infectious diseases and disorders; pharmaceutical preparations and substances; chemical preparations for the treatment of diseases; chemical preparations for pharmaceutical purposes; chemical preparations for medical purposes; Compositions and preparations containing lipophilic stains for scientific testing and research, biological testing and research, diagnostic testing and research, and environmental testing and research; compositions and preparations for the detection of pathogens; chemical compositions and preparations for environmental testing and research; Compositions and preparations containing lipophilic stains for the detection of pathogens; compositions and preparations for environmental testing provided as part of a kit; kits for environmental use comprised of compositions and preparations containing lipophilic stains; compositions and preparations for the detection of pathogens through use of lateral flow assays, immunochemistry, affinity chromatography, microfluidics, or nanotechnology

research services relating to treatments for infectious diseases; research services related to the development of vaccines; research and development of drug delivery platforms for use in the treatment of infectious diseases and disorders; research and development of compositions for use in targeted pharmaceutical therapies for the treatment of infectious diseases and disorders; scientific and technological services, namely, scientific analysis in the field of research and development relating to compositions for use in the treatment of infectious diseases; scientific and technological services, namely, research and development relating to compositions for use in the treatment of infectious diseases; scientific and technological services, namely, research and development relating to compositions for use in the treatment of pulmonary viral infections; design and development of compositions for use in the treatment of infectious diseases; consulting services relating to the design and development of compositions for use in the treatment of infectious diseases; consulting services relating to the design and development of targeted pharmaceutical therapies; Research services relating to the detection of pathogens; research and development of compositions and preparations for use in the detection of pathogens; scientific and technological services, namely, scientific analysis in the field of research and development relating to compositions and preparations for use in the detection of pathogens; scientific and technological services, namely, research and development relating to compositions and preparations for use in the detection of pathogens; design and development of compositions for use in the detection of pathogens; consulting services relating to the design and development of compositions and preparations for use in the detection of pathogens